Cancer Research Institute (CRI) is a family office. Based in New York, United States. The known portfolio counts 4 companies, including Infinitopes, SURGE Therapeutics, Cartography Biosciences and OverT Bio.
Is Cancer Research Institute (CRI) a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIHealthcare
- Focus
- AI ApplicationsBiotechDrug DiscoveryGenomicsImmuno-OncologyTranslational Medicine
Contacts
Who to pitch at Cancer Research Institute (CRI)
Cancer Research Institute (CRI) portfolio companies (4)
- Infinitopes
- SURGE Therapeutics
- Cartography Biosciences
- OverT Bio
Co-investors
Funds that share portfolio companies with Cancer Research Institute (CRI).
Similar funds
Showing 20 of 100
About Cancer Research Institute (CRI)
The firm's listing covers sectors AI and Healthcare, and focus areas AI Applications, Biotech, Drug Discovery and Genomics; known deals cluster at Seed, Series A and Series B.
Robert Dahl (Director), Trent Justus Kososki (Chairman of Associate Board) and Sharon Slade (Investor) are listed as the contacts to pitch at Cancer Research Institute (CRI).
Across the known portfolio, 20 co-investors appear alongside Cancer Research Institute (CRI), including National Cancer Research Institute, Octopus Ventures and Hawktail.
Frequently asked questions
What is Cancer Research Institute (CRI)?
Cancer Research Institute (CRI) is a family office based in New York, United States, with a known portfolio of 4 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does Cancer Research Institute (CRI) invest in?
Listed sectors include AI and Healthcare; listed focus areas include AI Applications, Biotech, Drug Discovery and Genomics. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does Cancer Research Institute (CRI) invest at?
The known deals of Cancer Research Institute (CRI) include Seed, Series A and Series B rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
Who should I pitch at Cancer Research Institute (CRI)?
All 3 people on file at Cancer Research Institute (CRI) are listed as contacts for the firm, each with their own profile page.
How do I contact Cancer Research Institute (CRI)?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 3 people attached to the firm have their own pages, each showing whether an address is on file for them.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal